The Sunshine Act: The Good, the Bad, and the Ugly
Industry Insights from Paul Meade, M. Sc, MPH The Sunshine Act is on the horizon, and all we know for certain is that things will be different. Will the changes be good, bad, or ugly for healthcare and the biopharmaceutical industry? Well, a bit of all three. But it is a bit like the Y2K …
The Sunshine Act: The Good, the Bad, and the Ugly Read More »
